T1	PROC 2150 2158	tratados
#1	AnnotatorNotes T1	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T2	DISO 98 119	enfermedad de Cushing
#2	AnnotatorNotes T2	C0221406; Pituitary-dependent Cushing's disease; Disease or Syndrome
T3	PROC 142 201	Estudio de fase II, multicéntrico, abierto y no comparativo
T4	PROC 207 266	evaluar la farmacocinética, farmacodinámica y tolerabilidad
T5	CHEM 270 282	osilodrostat
#3	AnnotatorNotes T5	C4330903; osilodrostat; Organic Chemical · Pharmacologic Substance
T6	DISO 311 332	enfermedad de Cushing
#4	AnnotatorNotes T6	C0221406; Pituitary-dependent Cushing's disease; Disease or Syndrome
T7	DISO 356 377	Enfermedad de Cushing
#5	AnnotatorNotes T7	C0221406; Pituitary-dependent Cushing's disease; Disease or Syndrome
T8	DISO 463 484	enfermedad de Cushing
#6	AnnotatorNotes T8	C0221406; Pituitary-dependent Cushing's disease; Disease or Syndrome
T9	PROC 500 507	cirugía
#7	AnnotatorNotes T9	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T10	PROC 547 555	operarse
#8	AnnotatorNotes T10	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T11	PROC 574 581	cirugía
#9	AnnotatorNotes T11	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T12	PROC 644 655	Diagnóstico
#10	AnnotatorNotes T12	C0011900; Diagnosis; Diagnostic Procedure
T13	DISO 659 680	Enfermedad de Cushing
#11	AnnotatorNotes T13	C0221406; Pituitary-dependent Cushing's disease; Disease or Syndrome
T14	CHEM 724 731	fármaco
#12	AnnotatorNotes T14	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T15	PROC 825 839	consentimiento
#13	AnnotatorNotes T15	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T16	DISO 897 909	macroadenoma
#14	AnnotatorNotes T16	C0346308; Pituitary macroadenoma; Neoplastic Process
T17	DISO 925 945	síntomas compresivos
T18	CHEM 998 1009	medicamento
#15	AnnotatorNotes T18	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T19	CHEM 1050 1058	cortisol
#16	AnnotatorNotes T19	C0020268; hydrocortisone; Hormone · Organic Chemical · Pharmacologic Substance
T20	CHEM 1076 1101	fármacos en investigación
#17	AnnotatorNotes T20	C0013230; Investigational New Drugs; Pharmacologic Substance
T21	DISO 1154 1171	hipersensibilidad
#18	AnnotatorNotes T21	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding
T22	DISO 1269 1282	tumor maligno
#19	AnnotatorNotes T22	C0006826; Malignant Neoplasms; Neoplastic Process
T23	ANAT 1296 1312	sistema orgánico
#20	AnnotatorNotes T23	C0460002; body system; Body System
T24	DISO 1317 1332	Deterioro renal
T25	CHEM 1363 1366	AST
#21	AnnotatorNotes T25	C0004002; Aspartate Transaminase; Amino Acid, Peptide, or Protein · Enzyme
T26	ANAT 1370 1375	suero
#22	AnnotatorNotes T26	C0229671; Serum; Body Substance | C0588987; Serum product; Body Substance
T27	PROC 1387 1404	bilirrubina total
#23	AnnotatorNotes T27	C0201913; Bilirubin, total measurement; Laboratory Procedure
T28	DISO 1436 1445	trombosis
#24	AnnotatorNotes T28	C0040053; Thrombosis; Pathologic Function
T29	DISO 1495 1513	Torsade de Pointes
#25	AnnotatorNotes T29	C0040479; Torsades de Pointes; Disease or Syndrome
T30	DISO 1529 1540	hipertensos
#26	AnnotatorNotes T30	C0020538; Hypertensive disease; Disease or Syndrome
T31	PROC 1619 1632	cirugía mayor
#27	AnnotatorNotes T31	C0679637; major surgery; Therapeutic or Preventive Procedure
T32	PROC 1696 1731	cirugía hipofisaria transesfenoidal
#28	AnnotatorNotes T32	C0747605; PITUITARY RESECTION TRANSSPHENOIDAL; Therapeutic or Preventive Procedure
T33	DISO 1815 1832	hipercortisolemia
#29	AnnotatorNotes T33	C0001622; Adrenal Gland Hyperfunction; Disease or Syndrome
T34	DISO 1902 1923	enfermedad de Cushing
#30	AnnotatorNotes T34	C0221406; Pituitary-dependent Cushing's disease; Disease or Syndrome
T35	CHEM 1954 1970	glucocorticoides
#31	AnnotatorNotes T35	C0017710; Glucocorticoids; Hormone · Organic Chemical
T36	DISO 2016 2031	Hipertiroidismo
#32	AnnotatorNotes T36	C0020550; Hyperthyroidism; Disease or Syndrome
T37	DISO 2061 2071	diabéticos
#33	AnnotatorNotes T37	C0011849; Diabetes Mellitus; Disease or Syndrome | C0241863; Diabetic; Finding | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T38	DISO 2076 2084	diabetes
#34	AnnotatorNotes T38	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T39	PROC 2659 2673	procedimientos
#35	AnnotatorNotes T39	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure | C0184661; Interventional procedure; Therapeutic or Preventive Procedure
T40	DISO 2184 2201	diabetes mellitus
#36	AnnotatorNotes T40	C0011849; Diabetes Mellitus; Disease or Syndrome | C1802373; Diabetes mellitus (incl subtypes); Disease or Syndrome
T41	PROC 2268 2286	prueba de embarazo
#37	AnnotatorNotes T41	C0032976; Pregnancy Tests; Diagnostic Procedure
T42	PROC 2378 2401	métodos anticonceptivos
#38	AnnotatorNotes T42	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T43	DISO 2487 2497	enfermedad
#39	AnnotatorNotes T43	C0012634; Disease; Disease or Syndrome
T44	PROC 2593 2608	estudio clínico
#40	AnnotatorNotes T44	C0008972; Clinical Research; Research Activity | C0008976; Clinical Trials; Research Activity
T45	CHEM 57 69	osilodrostat
#41	AnnotatorNotes T45	C4330903; osilodrostat; Organic Chemical · Pharmacologic Substance
T46	ANAT 618 626	Corporal
#42	AnnotatorNotes T46	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T47	PROC 1039 1058	niveles de cortisol
#43	AnnotatorNotes T47	C0201968; Cortisol Measurement; Laboratory Procedure
T48	CHEM 1174 1182	fármacos
#44	AnnotatorNotes T48	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T49	CHEM 1213 1225	osilodrostat
#45	AnnotatorNotes T49	C4330903; osilodrostat; Organic Chemical · Pharmacologic Substance
T50	ANAT 1327 1332	renal
#46	AnnotatorNotes T50	C0022646; Kidney; Body Part, Organ, or Organ Component | C1278978; Entire kidney; Body Part, Organ, or Organ Component
T51	PROC 1357 1360	ALT
#47	AnnotatorNotes T51	C0201836; Alanine aminotransferase measurement; Laboratory Procedure
T52	PROC 1363 1375	AST en suero
T53	CHEM 1387 1398	bilirrubina
#48	AnnotatorNotes T53	C0005437; Bilirubin; Biologically Active Substance · Organic Chemical
T54	ANAT 1553 1561	arterial
#49	AnnotatorNotes T54	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T55	ANAT 1704 1715	hipofisaria
#50	AnnotatorNotes T55	C0032005; Pituitary gland; Body Part, Organ, or Organ Component
T56	PROC 2117 2122	HbA1c
#51	AnnotatorNotes T56	C0202054; Glucohemoglobin measurement; Laboratory Procedure
T57	Date 13 17	2018
T58	LIVB 73 78	niños
#52	AnnotatorNotes T58	C0008059; Child; Age Group
T59	PHYS 235 250	farmacodinámica
#53	AnnotatorNotes T59	C0851347; Pharmacodynamics; Biologic Function
T60	PHYS 218 233	farmacocinética
#54	AnnotatorNotes T60	C0031327; Drug Kinetics; Physiologic Function
T61	LIVB 286 291	niños
#55	AnnotatorNotes T61	C0008059; Child; Age Group
T63	Age 443 458	de 6 a <18 años
T64	Neg_cue 582 584	no
T66	PHYS 701 707	tragar
#56	AnnotatorNotes T66	C0011167; Deglutition; Organism Function
T67	Form 708 719	comprimidos
#57	AnnotatorNotes T67	C0039225; Tablet Dosage Form; Biomedical or Dental Material
T70	LIVB 776 788	Progenitores
#58	AnnotatorNotes T70	C0030551; parent; Family Group | C0870134; Ancestor; Family Group
T71	LIVB 791 806	tutores legales
#59	AnnotatorNotes T71	C0023226; Legal Guardians; Population Group
T72	LIVB 883 892	Pacientes
#60	AnnotatorNotes T72	C0030705; Patients; Patient or Disabled Group
T74	LIVB 1519 1528	Pacientes
#61	AnnotatorNotes T74	C0030705; Patients; Patient or Disabled Group
T75	PHYS 1545 1561	presión arterial
#62	AnnotatorNotes T75	C0005823; Blood Pressure; Organism Function
T77	LIVB 1581 1590	Pacientes
#63	AnnotatorNotes T77	C0030705; Patients; Patient or Disabled Group
T78	Date 1641 1656	el mes anterior
T79	LIVB 1662 1671	Pacientes
#64	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T80	Duration 1740 1753	las 6 semanas
T83	Date 1933 1939	actual
T84	Duration 1982 1988	un mes
T86	LIVB 2051 2060	Pacientes
#65	AnnotatorNotes T86	C0030705; Patients; Patient or Disabled Group
T87	Neg_cue 2136 2138	no
T88	LIVB 2224 2236	investigador
#66	AnnotatorNotes T88	C0035173; Research Personnel; Professional or Occupational Group
T89	LIVB 2290 2312	mujeres en edad fértil
#67	AnnotatorNotes T89	C4324275; Woman of childbearing potential; Population Group
T90	Age 2301 2312	edad fértil
T91	PHYS 2434 2445	embarazadas
#68	AnnotatorNotes T91	C0032961; Pregnancy; Organism Function
T92	LIVB 2319 2328	Pacientes
#69	AnnotatorNotes T92	C0030705; Patients; Patient or Disabled Group
T93	LIVB 2330 2337	mujeres
#70	AnnotatorNotes T93	C0043210; Woman; Population Group
T94	Age 2342 2353	edad fértil
T95	PHYS 2462 2471	lactancia
#71	AnnotatorNotes T95	C0006147; Breast Feeding; Organism Function | C0022925; Lactation; Organ or Tissue Function
T96	Neg_cue 2358 2360	no
T97	LIVB 2426 2471	Mujeres embarazadas o en periodo de lactancia
#72	AnnotatorNotes T97	C0033011; Pregnant Women; Population Group | C4316174; Patients who are breastfeeding; Patient or Disabled Group
T98	LIVB 2525 2537	investigador
#73	AnnotatorNotes T98	C0035173; Research Personnel; Professional or Occupational Group
T101	LIVB 2576 2584	paciente
#74	AnnotatorNotes T101	C0030705; Patients; Patient or Disabled Group
T102	LIVB 81 93	adolescentes
#75	AnnotatorNotes T102	C0205653; Adolescent (age group); Age Group
T104	LIVB 407 442	Niños y adolescentes de ambos sexos
#76	AnnotatorNotes T104	C0870221; Boys; Age Group + C0870604; Female child; Age Group + C0001588; Adolescent, Female; Age Group + C0001588; Adolescent, Male; Age Group
T106	PHYS 2278 2286	embarazo
#77	AnnotatorNotes T106	C0032961; Pregnancy; Organism Function
T103	LIVB 294 306	adolescentes
#78	AnnotatorNotes T103	C0205653; Adolescent (age group); Age Group
T62	PROC 613 626	Peso Corporal
#79	AnnotatorNotes T62	C2985231; Body Weight Measurement; Diagnostic Procedure
T65	PROC 1120 1133	reclutamiento
#80	AnnotatorNotes T65	C0242800; Patient Recruitment; Research Activity
A1	Population_data T58 Age
A2	Population_data T102 Age
A3	Population_data T61 Age
A6	Population_data T104 Age
A7	Assertion T11 Negated
A4	Population_data T103 Age
A9	Assertion T1 Negated
A10	Assertion T42 Negated
A11	Population_data T89 Age
A12	Status T9 History_of
A13	Status T21 History_of
A14	Status T22 History_of
A15	Status T28 History_of
A16	Status T31 History_of
A17	Status T32 History_of
A18	Status T1 History_of
#81	AnnotatorNotes T4	C0201734; Pharmacokinetic study; Research Activity + C1709518; Pharmacodynamic Study; Research Activity + C3274448; Tolerability Study; Research Activity
#82	AnnotatorNotes T52	C1261155; AST serum measurement; Laboratory Procedure 
#83	AnnotatorNotes T83	C0521116; Current (present time); Temporal Concept 
T68	Neg_cue 2032 2034	no
T69	Quantifier_or_Qualifier 2035 2045	controlado
A5	Assertion T69 Negated
T73	Neg_cue 1562 1564	no
T76	Quantifier_or_Qualifier 1565 1575	controlada
A8	Assertion T76 Negated
T81	Quantifier_or_Qualifier 190 201	comparativo
A19	Assertion T81 Negated
T82	Neg_cue 187 189	no
T85	Neg_cue 745 747	no
T99	Neg_cue 759 761	ni
T100	Quantifier_or_Qualifier 762 770	partidos
A20	Assertion T100 Negated
T105	Quantifier_or_Qualifier 748 758	machacados
A21	Assertion T105 Negated
T107	Neg_cue 2547 2554	impedir
T108	Observation 2558 2608	participación del paciente en este estudio clínico
A22	Assertion T108 Negated
#84	AnnotatorNotes T108	C1278516; Patient participation status; Finding (?)
R1	Negation Arg1:T82 Arg2:T81	
R2	Negation Arg1:T64 Arg2:T11	
R3	Negation Arg1:T85 Arg2:T105	
R4	Negation Arg1:T99 Arg2:T100	
T109	Observation 1450 1468	Factores de riesgo
#85	AnnotatorNotes T109	C0035648; risk factors; Finding
T110	DISO 1472 1492	prolongación del QTc
#86	AnnotatorNotes T110	C1560305; Prolonged QTc interval; Pathologic Function
R5	Negation Arg1:T73 Arg2:T76	
R6	Negation Arg1:T68 Arg2:T69	
R7	Negation Arg1:T87 Arg2:T1	
T111	Quantifier_or_Qualifier 2159 2175	de manera óptima
A23	Assertion T111 Negated
R8	Has_Quantifier_or_Qualifier Arg1:T1 Arg2:T111	
R9	Negation Arg1:T96 Arg2:T42	
T112	Quantifier_or_Qualifier 2402 2420	altamente eficaces
A24	Assertion T112 Negated
R10	Has_Quantifier_or_Qualifier Arg1:T42 Arg2:T112	
R11	Negation Arg1:T107 Arg2:T108	
R12	Location_of Arg1:T23 Arg2:T22	
R13	Location_of Arg1:T50 Arg2:T24	
#87	AnnotatorNotes T24	C1565489; Renal Insufficiency; Disease or Syndrome
T113	Quantifier_or_Qualifier 1336 1352	moderado a grave
#88	AnnotatorNotes T113	C1299393; Moderate to severe; Qualitative Concept
R14	Has_Quantifier_or_Qualifier Arg1:T24 Arg2:T113	
R15	Location_of Arg1:T26 Arg2:T52	
R16	Location_of Arg1:T26 Arg2:T51	
T114	Result_or_Value 1376 1384	>3 x LSN
R17	Has_Result_or_Value Arg1:T51 Arg2:T114	
R18	Has_Result_or_Value Arg1:T52 Arg2:T114	
T115	Result_or_Value 1405 1415	>1,5 x LSN
R19	Has_Result_or_Value Arg1:T27 Arg2:T115	
R20	Before Arg1:T109 Arg2:T110	
R21	Before Arg1:T109 Arg2:T29	
R22	Experiences Arg1:T74 Arg2:T30	
R23	Experiences Arg1:T74 Arg2:T75	
R24	Location_of Arg1:T54 Arg2:T75	
R25	Location_of Arg1:T54 Arg2:T30	
R26	Has_Quantifier_or_Qualifier Arg1:T75 Arg2:T76	
R27	Overlap Arg1:T30 Arg2:T75	
R28	Overlap Arg1:T31 Arg2:T78	
R29	Experiences Arg1:T77 Arg2:T31	
R30	Experiences Arg1:T79 Arg2:T32	
R31	Location_of Arg1:T55 Arg2:T32	
R32	Overlap Arg1:T32 Arg2:T80	
T116	PROC 1770 1779	selección
#89	AnnotatorNotes T116	C0242802; Patient Selection; Research Activity
R33	Before Arg1:T32 Arg2:T116	
R34	Experiences Arg1:T79 Arg2:T33	
T117	Quantifier_or_Qualifier 1833 1844	persistente
#90	AnnotatorNotes T117	C0205322; Persistent; Temporal Concept
R35	Has_Quantifier_or_Qualifier Arg1:T33 Arg2:T117	
T118	Quantifier_or_Qualifier 1867 1879	persistentes
#91	AnnotatorNotes T118	C0205322; Persistent; Temporal Concept
T119	Observation 1847 1866	cambios bioquímicos
R36	Has_Quantifier_or_Qualifier Arg1:T119 Arg2:T118	
R37	Overlap Arg1:T119 Arg2:T34	
R38	Experiences Arg1:T79 Arg2:T119	
R39	Experiences Arg1:T79 Arg2:T34	
R40	Overlap Arg1:T35 Arg2:T83	
R41	Has_Duration_or_Interval Arg1:T35 Arg2:T84	
T120	PROC 2001 2010	selección
#92	AnnotatorNotes T120	C0242802; Patient Selection; Research Activity
R42	Before Arg1:T35 Arg2:T120	
T121	Quantifier_or_Qualifier 1971 1981	sistémicos
#93	AnnotatorNotes T121	C0205373; Systemic; Functional Concept
R43	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T121	
R44	Has_Quantifier_or_Qualifier Arg1:T36 Arg2:T69	
T122	Quantifier_or_Qualifier 1942 1950	previsto
#94	AnnotatorNotes T122	C1301732; Planned; Functional Concept
R45	Has_Quantifier_or_Qualifier Arg1:T35 Arg2:T122	
R46	Experiences Arg1:T86 Arg2:T37	
R47	Experiences Arg1:T86 Arg2:T38	
T123	Quantifier_or_Qualifier 2085 2099	mal controlada
#95	AnnotatorNotes T123	C3853134; Poorly controlled; Functional Concept
R48	Has_Quantifier_or_Qualifier Arg1:T38 Arg2:T123	
T124	Result_or_Value 2123 2129	>8,5 %
R51	Has_Result_or_Value Arg1:T56 Arg2:T124	
R52	Experiences Arg1:T86 Arg2:T56	
R53	Experiences Arg1:T86 Arg2:T1	
R54	Experiences Arg1:T86 Arg2:T40	
R55	Has_Age Arg1:T89 Arg2:T90	
R56	Experiences Arg1:T89 Arg2:T106	
R57	Experiences Arg1:T89 Arg2:T41	
T125	Result_or_Value 2242 2260	Resultado positivo
#96	AnnotatorNotes T125	C1446409; Positive; Finding
R58	Has_Result_or_Value Arg1:T41 Arg2:T125	
R59	Has_Age Arg1:T92 Arg2:T94	
R60	Has_Age Arg1:T93 Arg2:T94	
R61	Experiences Arg1:T92 Arg2:T42	
R62	Experiences Arg1:T93 Arg2:T42	
R63	Experiences Arg1:T97 Arg2:T91	
R64	Experiences Arg1:T97 Arg2:T95	
R65	Before Arg1:T43 Arg2:T108	
R66	Experiences Arg1:T101 Arg2:T43	
T126	Observation 2639 2673	cumplimiento de sus procedimientos
A25	Assertion T126 Negated
R67	Negation Arg1:T107 Arg2:T126	
R68	Experiences Arg1:T101 Arg2:T39	
R69	Experiences Arg1:T58 Arg2:T45	
R70	Experiences Arg1:T102 Arg2:T45	
R71	Experiences Arg1:T58 Arg2:T2	
R72	Experiences Arg1:T102 Arg2:T2	
R73	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T81	
R74	Experiences Arg1:T61 Arg2:T60	
R75	Experiences Arg1:T61 Arg2:T59	
R76	Experiences Arg1:T61 Arg2:T5	
R77	Experiences Arg1:T61 Arg2:T6	
R78	Experiences Arg1:T103 Arg2:T60	
R79	Experiences Arg1:T103 Arg2:T59	
R80	Experiences Arg1:T103 Arg2:T6	
R81	Experiences Arg1:T103 Arg2:T5	
R82	Has_Age Arg1:T104 Arg2:T63	
R83	Experiences Arg1:T104 Arg2:T8	
R84	Experiences Arg1:T104 Arg2:T9	
T127	Observation 511 520	fracasado
A26	Status T127 History_of
R85	Before Arg1:T9 Arg2:T127	
R86	Experiences Arg1:T104 Arg2:T127	
R87	Experiences Arg1:T104 Arg2:T11	
R88	Experiences Arg1:T104 Arg2:T10	
T128	Observation 532 543	a la espera
#97	AnnotatorNotes T128	C0422768; Patient on waiting list (finding); Finding
R89	Before Arg1:T128 Arg2:T10	
R90	Experiences Arg1:T104 Arg2:T128	
R91	Location_of Arg1:T46 Arg2:T62	
T129	Result_or_Value 627 640	mayor a 30 Kg
R92	Has_Result_or_Value Arg1:T62 Arg2:T129	
R93	Has_Drug_Form Arg1:T14 Arg2:T67	
T130	Observation 695 719	Poder tragar comprimidos
#98	AnnotatorNotes T130	C4543300; Ability to swallow pills; Finding
R94	Has_Quantifier_or_Qualifier Arg1:T67 Arg2:T105	
R95	Has_Quantifier_or_Qualifier Arg1:T67 Arg2:T100	
T131	Observation 840 852	asentimiento
#99	AnnotatorNotes T131	C1302239; Patient consented to clinical trial; Finding (?)
R96	Experiences Arg1:T72 Arg2:T16	
R97	Experiences Arg1:T72 Arg2:T17	
R98	Before Arg1:T17 Arg2:T16	
T132	Quantifier_or_Qualifier 910 920	complicado
#100	AnnotatorNotes T132	C0231242; Complicated; Functional Concept
R99	Has_Quantifier_or_Qualifier Arg1:T16 Arg2:T132	
T133	CONC 973 979	lavado
#101	AnnotatorNotes T133	C1710661; Washout Period; Temporal Concept
T134	Quantifier_or_Qualifier 957 969	insuficiente
#102	AnnotatorNotes T134	C0231180; Insufficient (qualifier); Qualitative Concept
R100	Has_Quantifier_or_Qualifier Arg1:T133 Arg2:T134	
R102	Overlap Arg1:T20 Arg2:T65	
R103	Causes Arg1:T48 Arg2:T21	
T136	Quantifier_or_Qualifier 1183 1225	de la misma clase química que osilodrostat
R104	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T136	
T137	Quantifier_or_Qualifier 1228 1248	de una clase similar
R105	Has_Quantifier_or_Qualifier Arg1:T48 Arg2:T137	
R106	Used_for Arg1:T14 Arg2:T66	
#103	AnnotatorNotes T127	C0162643; treatment failure; Finding
#104	AnnotatorNotes T137	C2348205; Similarity; Qualitative Concept
#105	AnnotatorNotes T111	C2698651; Optimum; Qualitative Concept (?)
#106	AnnotatorNotes T100	C1534709; Splitting; Functional Concept
A27	Experiencer T58 Patient
A28	Experiencer T102 Patient
A29	Experiencer T61 Patient
A30	Experiencer T103 Patient
A31	Experiencer T104 Patient
A32	Experiencer T71 Other
A33	Experiencer T70 Family_member
A34	Experiencer T72 Patient
A35	Experiencer T74 Patient
A36	Experiencer T77 Patient
A37	Experiencer T79 Patient
A38	Experiencer T86 Patient
A39	Experiencer T88 Other
A40	Experiencer T89 Patient
A41	Experiencer T93 Patient
A42	Experiencer T92 Patient
A43	Experiencer T97 Patient
A44	Experiencer T98 Other
A45	Experiencer T101 Patient
A46	Status T10 Future
A47	Status T35 Future
